Proposed Data Collection Submitted for Public Comment and Recommendations, 26795-26797 [2016-10399]

Download as PDF asabaliauskas on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 86 / Wednesday, May 4, 2016 / Notices nominations for membership on the BCCEDCAC. The committee provides advice and guidance to the Secretary, HHS, and the Director, CDC, regarding the early detection and control of breast and cervical cancer. The committee makes recommendations regarding national program goals and objectives; implementation strategies; program priorities, including surveillance, epidemiologic investigations, education and training, information dissemination, professional interactions and collaborations, and policy. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. The Secretary, HHS, acting through the Director, CDC, shall appoint to the advisory committee nominees with expertise in breast cancer, cervical cancer, medicine, public health, behavioral science, epidemiology, radiology, pathology, clinical medical care, health education, and surveillance. Two members may be representatives of the general public with personal experience in issues related to breast or cervical cancer early detection and control. Members may be invited to serve for up to four years. The next cycle of selection of candidates will conclude in the Summer of 2016, for selection of potential nominees to replace members whose terms will end on March 31, 2017. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of BCCEDCAC objectives. The U.S. Department of Health and Human Services will give close attention to equitable geographic distribution and to minority and female representation so long as the effectiveness of the Committee is not impaired. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, HIV status, disability, and cultural, religious, or socioeconomic status. Consideration is given to a broad representation of geographic areas within the U.S., with diverse representation of both genders, ethnic and racial minorities, and persons with disabilities. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: D Current curriculum vitae or resume, including complete contact information (name, affiliation, mailing address, telephone numbers, fax number, email address); D A 150 word biography for the nominee; VerDate Sep<11>2014 18:44 May 03, 2016 Jkt 238001 D At least one letter of recommendation from a person(s) not employed by the U.S. Department of Health and Human Services. Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by HHS. Nominations should be submitted (postmarked or received) by June 24, 2016: D Electronic submissions: You may submit nominations, including attachments, electronically to bccedcac@cdc.gov. D Regular, Express or Overnight Mail: Written nominations may be submitted to the following addressee only: Ms. Jameka Reese Blackmon, MBA, CMP c/o BCCEDCAC Secretariat, Centers for Disease Control and Prevention, 3719 North Peachtree Road, Building 100, Chamblee, Georgia 30341. Telephone and facsimile submissions cannot be accepted. Contact Person for More Information: Jameka R. Blackmon, MBA, CMP, Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Hwy. NE., Mailstop F76, Atlanta, Georgia 30341, Telephone (770) 488– 4880; Fax (770) 488–4760; Email: bccedcac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–10421 Filed 5–3–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–16–16AHI; Docket No. CDC–2016– 0041] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 26795 The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project entitled ‘‘CommunityBased Organization Outcome Monitoring Projects for CBO HIV Prevention Services Clients’’. DATES: Written comments must be received on or before July 5, 2016. ADDRESSES: You may submit comments, identified by Docket No. CDC–2016– 0041 by any of the following methods: • Federal eRulemaking Portal: Regulation.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. SUMMARY: Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information FOR FURTHER INFORMATION CONTACT: E:\FR\FM\04MYN1.SGM 04MYN1 26796 Federal Register / Vol. 81, No. 86 / Wednesday, May 4, 2016 / Notices collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. asabaliauskas on DSK3SPTVN1PROD with NOTICES Proposed Project ‘‘Community-Based Organization Outcome Monitoring Projects for CBO HIV Prevention Services Clients’’— New—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Community-Based Organizations (CBOs) play an essential role in reaching persons at high risk of transmitting and acquiring HIV infection. Through Cooperative Agreement #CDC–RFA– PS15–1502 (CBO–HPS), CDC funds 90 CBOs to provide comprehensive HIV prevention services to HIV-positive persons and high-risk HIV-negative persons. However, the CBO–HIV Prevention Services (HPS) awardees are not required to monitor or report on critical outcomes such as whether HIVpositive persons who are linked to HIV medical care were retained in care or prescribed ART, and whether high-risk VerDate Sep<11>2014 18:44 May 03, 2016 Jkt 238001 HIV-negative persons who were referred to Pre-Exposure Prophylaxis (PrEP) initiated its use. Also, CBO–HPS CBOs are not required to collect and report data about clients’ perceived barriers to accessing HIV prevention services. CBO–OMP will fund a subset of CBO– HPS awardees to collect and report data to CDC about the utilization and outcomes of the HIV prevention and support services. This will increase understanding of HIV prevention and support services received by CBO–HPS clients, the outcomes of these services, and successes and challenges related to service provision and utilization. The respondent universe will comprise clients at 15–18 CBOs funded by CBO–HPS. CBO–OPM is organized in two categories: Category 1—HIVpositive clients and Category 2—highrisk HIV-negative clients. This information collection will evaluate HIV-prevention services over time through participant interviews, record/chart review, CBO–HPS staff interviews, and focus groups. Participant interviews will include questions for participants living with HIV-positive and high-risk HIV-negative clients at CBOs funded by CBO–HPS about demographics, HIV-related risk behaviors, HIV prevention and support services received, service outcomes, and experiences with services over time; staff interviews about strategies for and barriers to recruiting and engaging clients in HIV prevention and support services; and focus groups with clients who are receiving HIV prevention services at CBOs. For Category 1, self-reported client interview data will be collected at baseline, 3, 6, 9 and 15 months. For Category 2, self-reported client level data will be collected at baseline, 3, 6, and 9 months. Participants will complete a 30-minute, staff-facilitated interview at baseline and 20-minute staff-facilitated interviews at each follow-up, to assess the outcomes of HIV-prevention services they receive. This project will also collect information from CBO–HPS Staff. Two CBO–HPS staff interviews will be conducted for Category 1 and two staff interviews will be conducted for Category 2. All interviews are expected to last 2.5 hours. This project will also collect information from participant focus groups. Respondents will also complete a short demographic questionnaire. Focus groups will occur twice during the project period and will last approximately 90 minutes. All electronic data will be password protected and accessible only to project staff and direct supervisors. Data will be PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 stored on network drives which are regularly backed up by staff. Participation in this project is strictly voluntary. The consent process will be implemented according to the local/ state policies of the funded agencies. Consent forms are provided. The consent process for CBO–OMP involves the agency staff providing an overview of the project that includes a description of the benefits of as well as the risks and discomforts to participation as well as the protections for the respondent’s privacy. Participants must sign the consent form prior to enrolling into the project. The information collected by each funded agency may include personally identifiable information, such as name and contact information, in order to provide continuity of service, follow-up of referrals, schedule follow-up interviews and other outreach activities. Personally identifiable information will be kept in a locked file cabinet and will be accessible only to appropriate agency staff. Any individually identifiable information collected by funded agencies will not be submitted to CDC. The category 1 information collection will occur over 33 months and will involve up to 15 CBOs. The population targeted by Category 1 are HIV-positive clients who are receiving CBO–HPS services and have been provided a CBO–HPS referral to HIV medical care. They will be screened, interviewed and CBO staff will collect their medical records related to their HIV-medical care visits, CD4 count and viral loads, and prescription to ART. The Category 2 information collection will occur over 21 months and involve up to 3 CBOs who will target high-risk HIV-negative clients who are receiving CBO–HPS services. CBOs will screen 225 persons each year. CBO staff will collect their medical records about medical care visits, PrEP prescriptions and information about which CBO–HPS referrals. Participants will be administered a baseline interview as well as interviews at 3 months, 6 months, and 9 months. Each CBO will also conduct two focus groups over the project period, one in each year of the evaluation. Each of the CBOs funded to participate in this project will be required to submit data they’ve collected each month to CDC, including the screener, medical records and CBO– HPS referrals, baseline interview, 3month follow-up interview, 6-month follow-up interview, 9-month follow-up interview, focus groups, and staff interviews, respectively. There is no cost to respondents other than their time. Total burden hours are 1,125. E:\FR\FM\04MYN1.SGM 04MYN1 26797 Federal Register / Vol. 81, No. 86 / Wednesday, May 4, 2016 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name General public ................................... General public ................................... CBO–HPS grantees .......................... Screener Participant Interview Category 1. Medical records abstraction Category 1. CBO–HPS Referrals Category 1 ..... Baseline Interview Category 1 ......... 3,6,9, and 15 Month Follow-up Interview Category 1. Screener Focus Group Category 1 Focus Group Questionnaire Category 1. Focus Group Category 1 ................. Staff Interview Category 1 ............... Data submission Category 1 and 2 Screener Participant Interview Category 2. Medical records abstraction Category 2. CBO–HPS Referrals Category 2 ..... Baseline Interview Category 2 ......... 3,6, and 9 Month Follow-up Interview Category 2. Screener Focus group Category 2 .. Focus Group Questionnaire Category 2. Focus Group Category 2 ................. Staff Interview Category 2 ............... Total ........................................... .......................................................... Facility office staff .............................. CBO–HPS grantees .......................... General public ................................... General public ................................... General public ................................... General Public ................................... General public ................................... CBO–HPS grantees .......................... CBO–OMP CBOs .............................. General public ................................... Facility office staff .............................. CBO–HPS grantees .......................... General public ................................... General public ................................... General Public ................................... General Public ................................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–10399 Filed 5–3–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention asabaliauskas on DSK3SPTVN1PROD with NOTICES Request for Nominations of Candidates To Serve on the Healthcare Infection Control Practices Advisory Committee (HICPAC) The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the Healthcare Infection Control Practices Advisory Committee (HICPAC). The Committee provides advice and guidance to the Secretary, Department of Health and Human Services (HHS); the Director, Centers for Disease Control and Prevention (CDC); the Deputy Director, Office of Infectious Diseases (OID), CDC; the Director, National Center for Emerging and Zoonotic VerDate Sep<11>2014 18:44 May 03, 2016 Jkt 238001 Frm 00025 Fmt 4703 Total burden (hours) 175 1 3/60 9 120 3 3/60 18 120 150 120 3 1 4 3/60 40/60 30/60 18 100 240 150 90 1 1 3/60 2/60 8 3 90 30 18 225 1 1 12 1 1.5 2.5 10/60 3/60 135 75 36 12 168 2 3/60 17 168 210 168 2 1 3 3/60 40/60 30/60 17 140 252 30 18 1 1 3/60 2/60 2 1 18 6 1 1 1.5 2.5 27 15 ........................ ........................ ........................ 1,125 Infectious Diseases (NCEZID), CDC; and the Director, Division of Healthcare Quality Promotion (DHQP), NCEZID, CDC, regarding the practice of infection control and strategies for surveillance, prevention, and control of healthcareassociated infections, antimicrobial resistance, and related events in settings where healthcare is provided, including hospitals, outpatient settings, long-termcare facilities, and home health agencies. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishment of HICPAC objectives. The Secretary, HHS, acting through the Director, CDC, shall appoint to the advisory committee nominees with expertise to provide advice regarding the practice of healthcare infection control, strategies for surveillance and prevention and control of healthcareassociated infections in United States healthcare facilities. Consideration is given to professional training and background, points of view represented, and upcoming issues to be addressed by the committee. Nominees may be invited to serve for four-year terms. The next cycle of selection of candidates will begin in the spring of 2016, for selection of potential nominees to PO 00000 Average burden response (hours) Number of responses per respondent Sfmt 4703 replace members whose terms will end on June 30, 2017. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of HICPAC’s objectives (https://www.cdc.gov/hicpac/ about.html). The U.S. Department of Health and Human Services will give close attention to equitable geographic distribution and to minority and female representation so long as the effectiveness of the Committee is not impaired. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, HIV status, disability, and cultural, religious, or socioeconomic status. Consideration is given to a broad representation of geographic areas within the U.S., with diverse representation of both genders, ethnic and racial minorities, and persons with disabilities. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: Current curriculum vitae or resume, including complete contact information (name, affiliation, mailing address, telephone numbers, fax number, email address) ; At least one letter of recommendation stating the E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 81, Number 86 (Wednesday, May 4, 2016)]
[Notices]
[Pages 26795-26797]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-10399]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-16-16AHI; Docket No. CDC-2016-0041]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project entitled ``Community-Based Organization 
Outcome Monitoring Projects for CBO HIV Prevention Services Clients''.

DATES: Written comments must be received on or before July 5, 2016.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0041 by any of the following methods:
     Federal eRulemaking Portal: Regulation.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information

[[Page 26796]]

collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    ``Community-Based Organization Outcome Monitoring Projects for CBO 
HIV Prevention Services Clients''--New--National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    Community-Based Organizations (CBOs) play an essential role in 
reaching persons at high risk of transmitting and acquiring HIV 
infection. Through Cooperative Agreement #CDC-RFA-PS15-1502 (CBO-HPS), 
CDC funds 90 CBOs to provide comprehensive HIV prevention services to 
HIV-positive persons and high-risk HIV-negative persons. However, the 
CBO-HIV Prevention Services (HPS) awardees are not required to monitor 
or report on critical outcomes such as whether HIV-positive persons who 
are linked to HIV medical care were retained in care or prescribed ART, 
and whether high-risk HIV-negative persons who were referred to Pre-
Exposure Prophylaxis (PrEP) initiated its use. Also, CBO-HPS CBOs are 
not required to collect and report data about clients' perceived 
barriers to accessing HIV prevention services.
    CBO-OMP will fund a subset of CBO-HPS awardees to collect and 
report data to CDC about the utilization and outcomes of the HIV 
prevention and support services. This will increase understanding of 
HIV prevention and support services received by CBO-HPS clients, the 
outcomes of these services, and successes and challenges related to 
service provision and utilization.
    The respondent universe will comprise clients at 15-18 CBOs funded 
by CBO-HPS. CBO-OPM is organized in two categories: Category 1--HIV-
positive clients and Category 2--high-risk HIV-negative clients.
    This information collection will evaluate HIV-prevention services 
over time through participant interviews, record/chart review, CBO-HPS 
staff interviews, and focus groups. Participant interviews will include 
questions for participants living with HIV-positive and high-risk HIV-
negative clients at CBOs funded by CBO-HPS about demographics, HIV-
related risk behaviors, HIV prevention and support services received, 
service outcomes, and experiences with services over time; staff 
interviews about strategies for and barriers to recruiting and engaging 
clients in HIV prevention and support services; and focus groups with 
clients who are receiving HIV prevention services at CBOs.
    For Category 1, self-reported client interview data will be 
collected at baseline, 3, 6, 9 and 15 months. For Category 2, self-
reported client level data will be collected at baseline, 3, 6, and 9 
months. Participants will complete a 30-minute, staff-facilitated 
interview at baseline and 20-minute staff-facilitated interviews at 
each follow-up, to assess the outcomes of HIV-prevention services they 
receive.
    This project will also collect information from CBO-HPS Staff. Two 
CBO-HPS staff interviews will be conducted for Category 1 and two staff 
interviews will be conducted for Category 2. All interviews are 
expected to last 2.5 hours.
    This project will also collect information from participant focus 
groups. Respondents will also complete a short demographic 
questionnaire. Focus groups will occur twice during the project period 
and will last approximately 90 minutes.
    All electronic data will be password protected and accessible only 
to project staff and direct supervisors. Data will be stored on network 
drives which are regularly backed up by staff. Participation in this 
project is strictly voluntary. The consent process will be implemented 
according to the local/state policies of the funded agencies. Consent 
forms are provided. The consent process for CBO-OMP involves the agency 
staff providing an overview of the project that includes a description 
of the benefits of as well as the risks and discomforts to 
participation as well as the protections for the respondent's privacy. 
Participants must sign the consent form prior to enrolling into the 
project.
    The information collected by each funded agency may include 
personally identifiable information, such as name and contact 
information, in order to provide continuity of service, follow-up of 
referrals, schedule follow-up interviews and other outreach activities. 
Personally identifiable information will be kept in a locked file 
cabinet and will be accessible only to appropriate agency staff. Any 
individually identifiable information collected by funded agencies will 
not be submitted to CDC.
    The category 1 information collection will occur over 33 months and 
will involve up to 15 CBOs. The population targeted by Category 1 are 
HIV-positive clients who are receiving CBO-HPS services and have been 
provided a CBO-HPS referral to HIV medical care. They will be screened, 
interviewed and CBO staff will collect their medical records related to 
their HIV-medical care visits, CD4 count and viral loads, and 
prescription to ART.
    The Category 2 information collection will occur over 21 months and 
involve up to 3 CBOs who will target high-risk HIV-negative clients who 
are receiving CBO-HPS services. CBOs will screen 225 persons each year. 
CBO staff will collect their medical records about medical care visits, 
PrEP prescriptions and information about which CBO-HPS referrals. 
Participants will be administered a baseline interview as well as 
interviews at 3 months, 6 months, and 9 months. Each CBO will also 
conduct two focus groups over the project period, one in each year of 
the evaluation.
    Each of the CBOs funded to participate in this project will be 
required to submit data they've collected each month to CDC, including 
the screener, medical records and CBO-HPS referrals, baseline 
interview, 3-month follow-up interview, 6-month follow-up interview, 9-
month follow-up interview, focus groups, and staff interviews, 
respectively. There is no cost to respondents other than their time. 
Total burden hours are 1,125.

[[Page 26797]]



                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
               Type of respondent                               Form name                    Number of     responses per     response      Total burden
                                                                                            respondents     respondent        (hours)         (hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
General public.................................  Screener Participant Interview Category             175               1            3/60               9
                                                  1.
Facility office staff..........................  Medical records abstraction Category 1.             120               3            3/60              18
CBO-HPS grantees...............................  CBO-HPS Referrals Category 1...........             120               3            3/60              18
General public.................................  Baseline Interview Category 1..........             150               1           40/60             100
General public.................................  3,6,9, and 15 Month Follow-up Interview             120               4           30/60             240
                                                  Category 1.
General public.................................  Screener Focus Group Category 1........             150               1            3/60               8
General Public.................................  Focus Group Questionnaire Category 1...              90               1            2/60               3
General public.................................  Focus Group Category 1.................              90               1             1.5             135
CBO-HPS grantees...............................  Staff Interview Category 1.............              30               1             2.5              75
CBO-OMP CBOs...................................  Data submission Category 1 and 2.......              18              12           10/60              36
General public.................................  Screener Participant Interview Category             225               1            3/60              12
                                                  2.
Facility office staff..........................  Medical records abstraction Category 2.             168               2            3/60              17
CBO-HPS grantees...............................  CBO-HPS Referrals Category 2...........             168               2            3/60              17
General public.................................  Baseline Interview Category 2..........             210               1           40/60             140
General public.................................  3,6, and 9 Month Follow-up Interview                168               3           30/60             252
                                                  Category 2.
General Public.................................  Screener Focus group Category 2........              30               1            3/60               2
General Public.................................  Focus Group Questionnaire Category 2...              18               1            2/60               1
General public.................................  Focus Group Category 2.................              18               1             1.5              27
CBO-HPS grantees...............................  Staff Interview Category 2.............               6               1             2.5              15
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............           1,125
--------------------------------------------------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-10399 Filed 5-3-16; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.